Bristol-Myers Squibb revealed that patients died in early multiple sclerosis trials; the stock price fell 2.5%.

Zhitongcaijing · 1d ago
Bristol-Myers Squibb revealed that patients died in early multiple sclerosis trials; the stock price fell 2.5%.